Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2010, Vol. 15 ›› Issue (10): 1133-1138.

Previous Articles     Next Articles

Effects of sirolimos on the expression of CD86, I-Ab and TLR4 on mice dendritic cells

HE Xiu-juan1, ZHANG Han3, LI Dong-mei4, QIU Yong5, LONG Jun1, AN Yun-qing1, HU Yong-xiu2   

  1. 1Department of Immunology, Capital Medical University, Beijing 100069, China;
    2Experimental Center, Capital Medical University, Beijing 100069, China;
    3Zhenguo Tumor Hospital of Integrated Traditional and Western Medicine, Beijing 100176, China;
    4Red-cross Blood Center, Beijing 100088, China;
    5Shiji Tan Hospital, Beijing 100038, China
  • Received:2010-09-04 Revised:2010-10-19 Published:2020-09-16

Abstract: AIM: To observe the effects of sirolimos (SRL) on the maturation of murine bone marrow-derived dendritic cells (DC) and on the transcription of toll-like receptor 4 (TLR4). METHODS: (1) DCs derived from C57BL/6 murine bone marrow cells were induced by cytokines, and morphology development of DCs was observed by inverted microscope and scanning electron microscope. (2) The expression of CD11c, CD86 and MHC classⅡmolecule of DCs were assessed by flow cytometry after treatment with SRL, and the changes of these molecules after stimulation with lipopolysaccharide (LPS). (3) The TLR4 mRNA transcription was detected by real-time PCR after treating with or without SRL. RESULTS: (1) Typical morphology of DCs can be observed during the different stages. (2) SRL inhibited the expression of CD86, I-Ab of DCs after stimulation with LPS. (3) The transcription of TLR4 mRNA was increased in SRL group. CONCLUSION: DCs treated with SRL can resist to promoting the maturation of DCs by LPS. The expression of TLR4 mRNA could be increased by SRL.

Key words: Sirolimos, Dendritic cell, Toll like receptors 4, CD86, I-Ab

CLC Number: